Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05732571

Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing

Post COVID REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing (REMEDY): COVID-19

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Nottingham · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A pilot Study To investigate the efficacy of a breathing intervention for improving persistent breathlessness due to dysregulated breathing following COVID-19 when compared to usual care.

Detailed description

Pilot RCT for upto 60 subjects across 2 arms Intervention A 12 session/six week, twice a week online group-based intervention based on breathing techniques including yoga practice directed by a specialist. Each group will aim for between 3- 6 participants. Each online session will be circa 40-50 minutes in length. This will include an Introduction and warm up; Breathing practice including yogic breathing and a final cool down and relaxation. Sessions will run at set times to ensure efficient use of resources but will try to accommodate different time points periods of the day when patients might be functioning best. Comparator A six week non-intervention (usual care) period will be recruited to, allowing a comparison to the intervention. Primary co-outcomes Change in * Breathlessness: Chronic Respiratory Disease Questionnaire-Dyspnoea domain (CRQ-D) * Functional measure: 5 repetition chair to stand (5RCTS) Secondary measures include other measures of breathlessness, function, adherence and completion (see full text for detail).

Conditions

Interventions

TypeNameDescription
OTHERBreathing techniques over 12 sessions / 6 weeks inc yogaas above

Timeline

Start date
2023-02-10
Primary completion
2024-07-15
Completion
2024-07-30
First posted
2023-02-17
Last updated
2024-06-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05732571. Inclusion in this directory is not an endorsement.